{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:25:07Z","timestamp":1792250707659,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejso.2020.12.007","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T08:29:22Z","timestamp":1611044962000},"page":"1157-1162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The value of lymph node ultrasound and whole body 18F-FDG PET\/CT in stage IIB\/C melanoma patients prior to SLNB"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8691-289X","authenticated-orcid":false,"given":"E.H.A.","family":"Stahlie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van der Hiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bruining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van de Wiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.M.","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.J.M.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2303-3468","authenticated-orcid":false,"given":"W.J.","family":"van Houdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejso.2020.12.007_bib1","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.12.007_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ejso.2020.12.007_bib3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.12.007_bib4","article-title":"Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma","author":"Mulder","year":"2020","journal-title":"Br J Dermatol"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2020.12.007_bib5","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.9560","article-title":"Validation, in silico and in\u00a0vitro, of a gene-signature based risk score in cutaneous melanoma","volume":"35","author":"Brunner","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.12.007_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cncr.24724","article-title":"Characteristics associated with early and late melanoma metastases","volume":"116","author":"Brauer","year":"2010","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.ejso.2020.12.007_bib7","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2020.12.007_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1470-2045(04)01609-2","article-title":"Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis","volume":"5","author":"Bafounta","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2020.12.007_bib9","article-title":"Preoperative ultrasound assessment of regional lymph nodes in melanoma patients does not provide reliable nodal staging: results from a large multicenter trial","author":"Thompson","year":"2019","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.ejso.2020.12.007_bib10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.ejca.2014.05.027","article-title":"Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients","volume":"50","author":"Voit","year":"2014","journal-title":"Eur J Canc"},{"issue":"4","key":"10.1016\/j.ejso.2020.12.007_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1245\/s10434-011-2172-7","article-title":"Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma","volume":"19","author":"Chai","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"10.1016\/j.ejso.2020.12.007_bib12","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1200\/JCO.2008.21.4882","article-title":"Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma","volume":"27","author":"Sanki","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"30","key":"10.1016\/j.ejso.2020.12.007_bib13","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1200\/JCO.2008.19.0033","article-title":"Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?","volume":"27","author":"Voit","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.12.007_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","article-title":"Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis","volume":"103","author":"Xing","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2020.12.007_bib15","article-title":"Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma","volume":"7","author":"Dinnes","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ejso.2020.12.007_bib16","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint committee on cancer (AJCC) 8th edition and beyond","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.12.007_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2019.03.010","article-title":"An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma","volume":"114","author":"Cook","year":"2019","journal-title":"Eur J Canc"},{"issue":"7","key":"10.1016\/j.ejso.2020.12.007_bib18","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.1055\/s-0032-1312827","article-title":"Can high-resolution ultrasound avoid the sentinel lymph-node biopsy procedure in the staging process of patients with stage I-II cutaneous melanoma?","volume":"33","author":"Marone","year":"2012","journal-title":"Ultraschall der Med"},{"issue":"5","key":"10.1016\/j.ejso.2020.12.007_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.2009.25.7428","article-title":"Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma","volume":"28","author":"Voit","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2020.12.007_bib20","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1245\/s10434-006-9046-4","article-title":"Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients","volume":"13","author":"Voit","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.12.007_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejso.2016.06.407","article-title":"Complications of sentinel lymph node biopsy for melanoma - a systematic review of the literature","volume":"43","author":"Moody","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.12.007_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1245\/s10434-009-0807-8","article-title":"Potential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up","volume":"17","author":"van Akkooi","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.12.007_bib23","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1016\/S1470-2045(19)30332-8","article-title":"Neoadjuvant systemic therapy in melanoma: recommendations of the international neoadjuvant melanoma consortium","volume":"20","author":"Amaria","year":"2019","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.12.007_bib24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S1470-2045(19)30151-2","article-title":"Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial","volume":"20","author":"Rozeman","year":"2019","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2020.12.007_bib25","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","article-title":"Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma","volume":"24","author":"Blank","year":"2018","journal-title":"Nat Med"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2020.12.007_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS9605","article-title":"Personalized response-driven adjuvant therapy after combination ipilimumab and nivolumab in high-risk resectable stage III melanoma: PRADO trial","volume":"37","author":"Reijers","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2020.12.007_bib27","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1468-3083.2011.04312.x","article-title":"Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases","volume":"26","author":"Wagner","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.ejso.2020.12.007_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archsurg.141.3.284","article-title":"Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma","volume":"141","author":"Clark","year":"2006","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.ejso.2020.12.007_bib29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.0007-0963.2004.05870.x","article-title":"Baseline staging in cutaneous malignant melanoma","volume":"150","author":"Hafner","year":"2004","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ejso.2020.12.007_bib30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/SLA.0b013e31824a5742","article-title":"Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma","volume":"255","author":"Bastiaannet","year":"2012","journal-title":"Ann Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320312282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320312282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:39:03Z","timestamp":1760060343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320312282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0748798320312282"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.12.007","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of lymph node ultrasound and whole body 18F-FDG PET\/CT in stage IIB\/C melanoma patients prior to SLNB","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}